Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2595-2608

  Jiang, Shujun ^a   Shi, Zhen ^a   Li, Changyong ^b   Ma, Chunlei ^a   Bai, Xianyong ^a   Wang, Chaoyun ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Cell migration; Hydroxysafflor yellow A; Inflammatory cytokines; Liver ischemia reperfusion injury; Macrophage; Reactive oxygen species

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CHALCONE; CYTOKINE; GELATINASE B; HYDROXYSAFFLOR YELLOW A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MMP9 PROTEIN, MOUSE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL LINE; CHEMOTAXIS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; LIVER; LIVER DISEASES; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHALCONE; CHEMOTAXIS; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION MEDIATORS; LIVER; LIVER DISEASES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; QUINONES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84902499683     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Jaeschke H and Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-1257.
2. Bahde R and Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 2010; 97: 1461-1475.
3. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A and Farges O. Seven hundred forty- seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46.
4. Zhai Y, Petrowsky H, Hong JC, Busuttil RW and Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation--from bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10: 79-89.
5. Klune JR and Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am 2010; 90: 665-677.
6. Zhai Y, Busuttil RW and Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune- mediated tissue inflammation. Am J Transplant 2011; 11: 1563-1569.
7. Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B and Seifalian A. Liver ischemia/reperfusion injury: processes in inflammatory networks-- a review. Liver Transpl 2010; 16: 1016-1032.
8. Bilzer M, Roggel F and Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26: 1175-1186.
9. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E and Geller DA. Factors in the pathophysiology of the liver ischemia- reperfusion injury. J Surg Res 2008; 147: 153-159.
10. Bhogal RH, Sutaria R and Afford SC. Hepatic liver ischemia/reperfusion injury: processes in inflammatory networks--a review. Liver Transpl 2011; 17: 95; author reply 96.
11. Tomiyama K, Ikeda A, Ueki S, Nakao A, Stolz DB, Koike Y, Afrazi A, Gandhi C, Tokita D, Geller DA and Murase N. Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepat ic ischemia/reperfusion injury in rats. Hepatology 2008; 48: 1608-1620.
12. Lentsch AB, Kato A, Yoshidome H, McMasters KM and Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173.
13. Feng ZM, He J, Jiang JS, Chen Z, Yang YN and Zhang PC. NMR solution structure study of the representative component hydroxysafflor yellow A and other quinochalcone C-glycosides from Carthamus tinctorius. J Nat Prod 2013; 76: 270-274.
14. He H, Yang X, Shi M, Zeng X, Yang J, Wu L and Li L. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. J Pharm Pharmacol 2008; 60: 115-123.
15. Tian Y, Yang ZF, Li Y, Qiao Y, Yang J, Jia YY and Wen AD. Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats. J Ethnopharmacol 2010; 129: 1-4.
16. Ye SY and Gao WY. Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats. Arch Pharm Res 2008; 31: 1010-1015.
17. Sun CY, Pei CQ, Zang BX, Wang L and Jin M. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice. Phytother Res 2010; 24: 1788-1795.
18. Wang CY, Liu Q, Huang QX, Liu JT, He YH, Lu JJ and Bai XY. Activation of PPARgamma is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Phytomedicine 2013; 20: 592-599.
19. Wang C, Huang Q, Wang C, Zhu X, Duan Y, Yuan S and Bai X. Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A. Toxicol Appl Pharmacol 2013; 272: 895-904.
20. Li C and Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227-241.
21. Jiang SJ, Li W and An W. Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function. Hum Gene Ther 2013; 24: 443-456.
22. Abe Y, Hines IN, Zibari G, Pavlick K, Gray L, Kitagawa Y and Grisham MB. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med 2009; 46: 1-7.
23. Hanschen M, Zahler S, Krombach F and Khandoga A. Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia- reperfusion. Transplantation 2008; 86: 710-718.
24. Hamada T, Fondevila C, Busuttil RW and Coito AJ. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology 2008; 47: 186-198.
25. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H and Okumura K. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci U S A 1998; 95: 3537-3542.
26. Liu YN, Zhou ZM and Chen P. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clin Exp Pharmacol Physiol 2008; 35: 211-216.
27. Nie PH, Zhang L, Zhang WH, Rong WF and Zhi JM. The effects of hydroxysafflor yellow A on blood pressure and cardiac function. J Ethnopharmacol 2012; 139: 746-750.
28. Liu SX, Zhang Y, Wang YF, Li XC, Xiang MX, Bian C and Chen P. Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation- induced apoptosis in H9c2 cardiomyocytes. Int J Cardiol 2012; 160: 95-101.
29. Ivashkiv LB. Inflammatory signaling in macrophages:transitions from acute to tolerant and alternative activation states. Eur J Immunol 2011; 41: 2477-2481.
30. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF and Gores GJ. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003; 38: 1188-1198.
31. Hsu CM, Wang JS, Liu CH and Chen LW. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 2002; 17: 280-285.
32. Nace GW, Huang H, Klune JR, Eid RE, Rosborough BR, Korff S, Li S, Shapiro RA, Stolz DB, Sodhi CP, Hackam DJ, Geller DA, Billiar TR and Tsung A. Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology 2013; 58: 374-387.
33. Perry BC, Soltys D, Toledo AH and Toledo-Pereyra LH. Tumor necrosis factor-alpha in liver ischemia/reperfusion injury. J Invest Surg 2011; 24: 178-188.
34. Schwabe RF and Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290: G583-589
35. Lehmann TG, Wheeler MD, Schwabe RF, Connor HD, Schoonhoven R, Bunzendahl H, Brenner DA, Jude Samulski R, Zhong Z and Thurman RG. Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat. Hepatology 2000; 32: 1255-1264.
36. Soumyarani VS and Jayakumari N. Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-alpha, MMP-9, and MMP-2. Mol Cell Biochem 2012; 366: 277-285.
37. Schwabe RF and Brenner DA. Nuclear factor-kappaB in the liver: friend or foe? Gastroenterology 2007; 132: 2601-2604.
38. Llacuna L, Mari M, Lluis JM, Garcia-Ruiz C, Fernandez-Checa JC and Morales A. Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol 2009; 174: 1776-1785.
39. Narang H and Krishna M. Mitogen-activated protein kinases: specificity of response to dose of ionizing radiation in liver. J Radiat Res 2004; 45: 213-220.